Organogenesis Holdings (ORGO) Short-term Investments (2017 - 2026)
Organogenesis Holdings (ORGO) posted quarterly Short-term Investments of $720000.0 for Q1 2026, up 26.54% year-over-year from $569000.0 in Q1 2025, and up 10.43% quarter-over-quarter from $652000.0 in Q4 2025.
Organogenesis Holdings (ORGO) Short-term Investments (2017 - 2026) Analysis & Trends
Organogenesis Holdings' Short-term Investments history runs 10 years deep, the most recent figure standing at $720000.0 for Q1 2026.
- In Q1 2026, Short-term Investments rose 26.54% year-over-year to $720000.0; the TTM figure through Mar 2026 stood at $720000.0 (up 26.54% YoY), while the FY2025 annual figure was $652000.0, up 12.41% from the prior year.
- Short-term Investments for Q1 2026 stood at $720000.0, up from $652000.0 in the prior quarter.
- The five-year high for Short-term Investments was $812000.0 in Q4 2022, with the low at $498000.0 in Q4 2023.
- The 5-year median for Short-term Investments is $627000.0 (2025), against an average of $644117.6.
- The sharpest annual moves came in 2022 and 2023: Short-term Investments surged 58.32% in 2022, then slumped 38.67% in 2023.
- Organogenesis Holdings' Short-term Investments stood at $812000.0 in 2022, then plunged by 38.67% to $498000.0 in 2023, then increased by 16.47% to $580000.0 in 2024, then rose by 12.41% to $652000.0 in 2025, then increased by 10.43% to $720000.0 in 2026.
- Business Quant data shows ORGO's Short-term Investments at $720000.0 in Q1 2026, $652000.0 in Q4 2025, and $627000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Organogenesis Holdings | 238.69 Mn | 191.85 Mn | 20.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 747,000.00 |
| Mar 31, 2026 | 720,000.00 |
| Dec 31, 2025 | 652,000.00 |
| Sep 30, 2025 | 627,000.00 |
| Jun 30, 2025 | 659,000.00 |
| Mar 31, 2025 | 569,000.00 |
| Dec 31, 2024 | 580,000.00 |
| Sep 30, 2024 | 586,000.00 |
| Jun 30, 2024 | 575,000.00 |
| Mar 31, 2024 | 720,000.00 |
| Dec 31, 2023 | 498,000.00 |
| Sep 30, 2023 | 599,000.00 |
| Jun 30, 2023 | 591,000.00 |
| Mar 31, 2023 | 721,000.00 |
| Dec 31, 2022 | 812,000.00 |
| Sep 30, 2022 | 771,000.00 |
| Jun 30, 2022 | 665,000.00 |
| Mar 31, 2022 | 605,000.00 |
| Dec 31, 2021 | 599,000.00 |
| Sep 30, 2021 | 487,000.00 |